Jerry Nick is a Respiratory physician affiliated with National Jewish Health. OpenAlex indexes 215 publications with 10,080 citations (h-index 51); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-388-4461Registry record last updated 26 Apr 2013.
Clinical trials
- Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
Sponsor: National Jewish Health
- Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographY
Sponsor: National Jewish Health
- Prospective Analysis of Urine LAM to Eliminate NTM Sputum Screening
Sponsor: Jerry A. Nick, M.D.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Paratek Pharmaceuticals, Inc.Program year20253 payments
- ABBVIE INC.Program year20252 payments
- Insmed, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 1997–2022 per NIH RePORTER. The latest:
- Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria
National Jewish Health
FY2022$410,000R01HL146228 - Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria
National Jewish Health
FY2021$410,000R01HL146228 - Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria
National Jewish Health
FY2020$410,000R01HL146228
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Population Genomics of <i>Mycobacterium abscessus</i> from U.S. Cystic Fibrosis Care Centers
Annals of the American Thoracic Society
2021 - A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
Journal of Cystic Fibrosis
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Crapo, MD
National Jewish Health
Barry Make, MD
National Jewish Health
Jeffrey Swigris, DO
National Jewish Health
Michael Wechsler, MD
National Jewish Health
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”